This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Francisco S. Martinez-Deben, MD; Pascual Sesma, MD; Juan A. Garrido, MD
Ferrol (Coruña), Spain

Arch Intern Med. 1992;152(12):2506-2507.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Systemic sclerosis is a chronic, often progressive disease with no definite treatment at the present moment. The limited form has some clinically distinctive characteristic and a rather better prognosis, but some form of effective therapy is lacking too.¹ Recently, we have assayed, in one patient, a rather new modality of therapy, the angiotensin-converting enzyme inhibitor enalapril, a widely available, low-toxic drug, with fairly good results.

Report of a Case.—

A 33-year-old woman presented with joint pain and swelling. Two years before, she began to experience arthralgia, principally in the hands, wrists, and knees. Later, articular swelling, morning stiffness, and Raynaud's phenomenon appeared. She developed leg edema, with pain on squatting and impossibility to complete handgrip. She smoked 20 cigarettes a day and denied alcohol consumption, illicit-drug abuse, or toxic exposure. On examination, she was a thin young woman who looked well, without cyanosis or pallor. Her . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?